FTC wades into Pfizer/Teva lawsuit
Katy Oglethorpe • Tuesday, 14 August 2012 (9 months ago)
The US Federal Trade Commission (FTC) has intervened in litigation against pharmaceutical companies Pfizer and Teva, calling no-fee settlements reached over patent challenges a “convenient method” to delay drug entry.
Subscription required to view this article
This content can only be accessed by subscribers.
Please note: If you would like online access to all archived content, you will need a subscription with premium access.
Please see Subscriptions.
If you are a subscriber, please login: